Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues (QFR101385USNO)

Q2 2025: 176,566
Updated: Sep 9, 2025 9:07 AM CDT
Q2 2025:  176,566  
Q1 2025:  165,013  
Q4 2024:  178,774  
Q3 2024:  174,839  
Q2 2024:  164,748  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates

2017-09-06 2025-09-09
 
Source    

2017-09-06 2025-09-09
 
Release    

2017-09-06 2025-09-09
 
Units    

2017-09-06 2025-09-09
 
Frequency    

2017-09-06 2025-09-09
 
Seasonal Adjustment    

2017-09-06 2025-09-09
 
Notes    

2017-09-06 2025-09-09